Last reviewed · How we verify

NCT05108298

Improving Adolescent and Young Adult Self-Reported Data in ECOG-ACRIN Trials

Recruiting now NA Last updated 3 April 2026
What this trial tests

NA trial testing Questionnaires in Breast Cancer, NOS in 400 participants. Currently enrolling.

Timeline
10 November 2021
Primary endpoint
1 May 2027
1 May 2027

Quick facts

Lead sponsorEastern Cooperative Oncology Group
PhaseNA
StatusRecruiting now
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingnone
Primary purposehealth services research
Enrollment400
Start date10 November 2021
Primary completion1 May 2027
Estimated completion1 May 2027
Sites347 locations across United States

Drugs / interventions tested

Conditions studied

Sponsor

Eastern Cooperative Oncology Group

Who can join

Adults 18 to 39, any sex, with Breast Cancer, NOS or CNS Primary Tumor, NOS. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The purpose of this study is to evaluate feasibility and acceptability of completing PROs among AYAs randomized to Choice PRO vs Fixed PRO.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of Questionnaires

Trials testing the same drug.

Other Eastern Cooperative Oncology Group trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05108298.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing